These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11564823)

  • 1. Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells.
    Petry F; Botto M; Holtappels R; Walport MJ; Loos M
    J Immunol; 2001 Oct; 167(7):4033-7. PubMed ID: 11564823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice.
    Cortes-Hernandez J; Fossati-Jimack L; Petry F; Loos M; Izui S; Walport MJ; Cook HT; Botto M
    Eur J Immunol; 2004 Dec; 34(12):3713-22. PubMed ID: 15517607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
    Botto M; Dell'Agnola C; Bygrave AE; Thompson EM; Cook HT; Petry F; Loos M; Pandolfi PP; Walport MJ
    Nat Genet; 1998 May; 19(1):56-9. PubMed ID: 9590289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation.
    Mitchell DA; Taylor PR; Cook HT; Moss J; Bygrave AE; Walport MJ; Botto M
    J Immunol; 1999 May; 162(10):5676-9. PubMed ID: 10229798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q deficiency and autoimmunity: the effects of genetic background on disease expression.
    Mitchell DA; Pickering MC; Warren J; Fossati-Jimack L; Cortes-Hernandez J; Cook HT; Botto M; Walport MJ
    J Immunol; 2002 Mar; 168(5):2538-43. PubMed ID: 11859149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.
    Bulla R; Tripodo C; Rami D; Ling GS; Agostinis C; Guarnotta C; Zorzet S; Durigutto P; Botto M; Tedesco F
    Nat Commun; 2016 Feb; 7():10346. PubMed ID: 26831747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.
    Robson MG; Cook HT; Botto M; Taylor PR; Busso N; Salvi R; Pusey CD; Walport MJ; Davies KA
    J Immunol; 2001 Jun; 166(11):6820-8. PubMed ID: 11359841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1q knock-out mice for the study of complement deficiency in autoimmune disease.
    Botto M
    Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor in a case with C1q deficiency associated with refractory systemic lupus erythematosus.
    Matsumura R; Mochizuki S; Maruyama N; Morishita Y; Kawaguchi H; Okada S; Tsumura M; Kaji S; Shimizu J; Shimada A; Kobayashi M
    Int J Hematol; 2021 Feb; 113(2):302-307. PubMed ID: 33000368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice.
    Pickering MC; Fischer S; Lewis MR; Walport MJ; Botto M; Cook HT
    J Invest Dermatol; 2001 Jul; 117(1):52-8. PubMed ID: 11442749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration.
    Jiao H; Rutar M; Fernando N; Yednock T; Sankaranarayanan S; Aggio-Bruce R; Provis J; Natoli R
    Mol Neurodegener; 2018 Aug; 13(1):45. PubMed ID: 30126455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact B cell tolerance in the absence of the first component of the classical complement pathway.
    Cutler AJ; Cornall RJ; Ferry H; Manderson AP; Botto M; Walport MJ
    Eur J Immunol; 2001 Jul; 31(7):2087-93. PubMed ID: 11449362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice.
    Cohen JI; Roychowdhury S; McMullen MR; Stavitsky AB; Nagy LE
    Gastroenterology; 2010 Aug; 139(2):664-74, 674.e1. PubMed ID: 20416309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain.
    Fonseca MI; Chu SH; Hernandez MX; Fang MJ; Modarresi L; Selvan P; MacGregor GR; Tenner AJ
    J Neuroinflammation; 2017 Mar; 14(1):48. PubMed ID: 28264694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice.
    Trendelenburg M; Manderson AP; Fossati-Jimack L; Walport MJ; Botto M
    Immunology; 2004 Sep; 113(1):80-8. PubMed ID: 15312138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical pathway deficiencies - A short analytical review.
    Truedsson L
    Mol Immunol; 2015 Nov; 68(1):14-9. PubMed ID: 26038300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus.
    Heidari Y; Bygrave AE; Rigby RJ; Rose KL; Walport MJ; Cook HT; Vyse TJ; Botto M
    Genes Immun; 2006 Oct; 7(7):592-9. PubMed ID: 16943797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C1q Enhances Primary Hemostasis.
    Donat C; Kölm R; Csorba K; Tuncer E; Tsakiris DA; Trendelenburg M
    Front Immunol; 2020; 11():1522. PubMed ID: 32765527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus with C1q deficiency: treatment with fresh frozen plasma.
    Ekinci Z; Ozturk K
    Lupus; 2018 Jan; 27(1):134-138. PubMed ID: 29113537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.